Kovitz Investment Group Partners, LLC Abb Vie Inc. Transaction History
Kovitz Investment Group Partners, LLC
- $10.5 Billion
- Q2 2024
A detailed history of Kovitz Investment Group Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 23,022 shares of ABBV stock, worth $4.62 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
23,022
Previous 14,832
55.22%
Holding current value
$4.62 Million
Previous $2.7 Million
46.22%
% of portfolio
0.04%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding ABBV
# of Institutions
3,785Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$10.4 Billion0.84% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...